Sodium channel blockers for neuroprotection in multiple sclerosis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Sodium Channel Blockers for Neuroprotection in Multiple Sclerosis." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/432673/all/Dopamine_for_prevention_of_morbidity_and_mortality_in_term_newborn_infants_with_suspected_perinatal_asphyxia_Edited__no_change_to_conclusions_. Accessed 23 April 2024.
Sodium channel blockers for neuroprotection in multiple sclerosis. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432673/all/Dopamine_for_prevention_of_morbidity_and_mortality_in_term_newborn_infants_with_suspected_perinatal_asphyxia_Edited__no_change_to_conclusions_. Accessed April 23, 2024.
Sodium channel blockers for neuroprotection in multiple sclerosis. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/432673/all/Dopamine_for_prevention_of_morbidity_and_mortality_in_term_newborn_infants_with_suspected_perinatal_asphyxia_Edited__no_change_to_conclusions_
Sodium Channel Blockers for Neuroprotection in Multiple Sclerosis [Internet]. In: Cochrane Abstracts. [cited 2024 April 23]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/432673/all/Dopamine_for_prevention_of_morbidity_and_mortality_in_term_newborn_infants_with_suspected_perinatal_asphyxia_Edited__no_change_to_conclusions_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Sodium channel blockers for neuroprotection in multiple sclerosis
ID - 432673
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/432673/all/Dopamine_for_prevention_of_morbidity_and_mortality_in_term_newborn_infants_with_suspected_perinatal_asphyxia_Edited__no_change_to_conclusions_
DB - Evidence Central
DP - Unbound Medicine
ER -